Delivery Order SPE2DB22D2214-SPE2DB25FS4QC
Award Date
4/11/25
Potential Completion Date
4/14/25
Potential Value
$3.8K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $3,880.73 and a completion date of June 16, 2025. It is for the delivery of Colestipol HCL 1 GM Tablet 120s, a pharmaceutical product. The contract is not set aside and is an open competition. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery Contract (IDC)...
This federal contract award, valued at $1,753.71, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order and is for the supply of Colestipol HCL 1 GM Tablets in quantities of 120 tablets. The award is part of a larger Indefinite Delivery Contract (IDC) worth $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical. This IDC serves as a primary...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Colestipol HCL 1 GM Tablets. The contract has a ceiling value of $4,411.65 and a period of performance through May 9, 2025. It is a firm-fixed-price contract, with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the delivery of 4,564,220,957 units of Colestipol HCl 1 gram tablets. The $4,005.65 firm fixed price delivery order has an ultimate completion date of April 10, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00 through December 31, 2025, which serves as the primary...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Colestipol HCL 1 GM Tablets, with a ceiling value of $1,029.69 and a period of performance through May 30, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00,...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Colestipol HCL 1 GM Tablets, with a ceiling value of $1,157.80 and a performance period ending on May 20, 2025. The contract is a Firm Fixed Price type and is not set aside for any specific business category. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price valued at $1,321.02 and runs through January 29, 2025. It is not designated as a set-aside contract. The award is for the delivery of COLESTIPOL HCL 1 GM TABLET 120S, a pharmaceutical product, to support military and federal healthcare programs. AmerisourceBergen...
This federal contract award, with ID SPE2DB24D1107|SPE2DB25FZFD2, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,221.86 firm fixed-price delivery order is for the supply of 4,568,092,834 tablets of Colestipol HCL 1 GM, a medication used to treat high cholesterol. The contract has an ultimate completion date of May 1, 2025 and was awarded on April 30, 2025. This award is not designated...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Colestipol HCL 1 GM Tablets, a medication used to treat high cholesterol. The contract has a firm fixed price and a ceiling value of $4,058.54. It was awarded on May 7, 2025, with a final completion date of May 8, 2025. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Colestipol Hydrochloride 1 gram tablets, a medication used to treat high cholesterol. The contract has a ceiling value of $2,250.86 and is a firm fixed-price contract with an ultimate completion date of April 22, 2025. The contract is not designated as a set-aside and was awarded on April...